7月22日,截至收盘,AI制药(医疗)概念下跌0.58%,板块资金流出17542.35万。上涨个股家数11个,下跌个股家数28个。
板块跌幅居前的十大熊股分别是:嘉和美康(-3.48%)、润达医疗(-2.69%)、皓元医药(-2.41%)、博济医药(-2.08%)、贝瑞基因(-1.9%)、康缘药业(-1.85%)、百诚医药(-1.83%)、岩山科技(-1.76%)、真视通(-1.71%)、金城医药(-1.58%)、尔康制药(-1.43%)、光正眼科(-1.26%)、安必平(-1.24%)、电科数字(-1.19%)、可孚医疗(-1.14%)、理邦仪器(-1.11%)、华海药业(-1.05%)、安科生物(-0.95%)、翔宇医疗(-0.94%)、川宁生物(-0.87%)
序 | 代码 | 股票名称 | 现价 | 涨跌幅 | 主力资金净额 | 主力资金净占比 |
1 | 688246 | 嘉和美康 | 32.7 | -3.48 | -389.68万 | -1.57 |
2 | 603108 | 润达医疗 | 18.12 | -2.69 | -7882.65万 | -18.36 |
3 | 688131 | 皓元医药 | 56.3 | -2.41 | -988.64万 | -2.30 |
4 | 300404 | 博济医药 | 10.37 | -2.08 | -665.43万 | -2.28 |
5 | 000710 | 贝瑞基因 | 13.95 | -1.9 | -3423.72万 | -14.55 |
6 | 600557 | 康缘药业 | 15.96 | -1.85 | -91.88万 | -0.28 |
7 | 301096 | 百诚医药 | 48.25 | -1.83 | -1138.23万 | -6.56 |
8 | 002195 | 岩山科技 | 5.58 | -1.76 | -6682.83万 | -6.17 |
9 | 002771 | 真视通 | 16.1 | -1.71 | -938.97万 | -8.94 |
10 | 300233 | 金城医药 | 18.1 | -1.58 | -2203.40万 | -3.43 |
11 | 300267 | 尔康制药 | 3.45 | -1.43 | -903.95万 | -5.29 |
12 | 002524 | 光正眼科 | 4.69 | -1.26 | 230.26万 | 4.72 |
13 | 688393 | 安必平 | 32.59 | -1.24 | -1224.82万 | -6.42 |
14 | 600850 | 电科数字 | 25.7 | -1.19 | -1340.68万 | -4.63 |
15 | 301087 | 可孚医疗 | 35.71 | -1.14 | -1401.55万 | -20.14 |
16 | 300206 | 理邦仪器 | 12.52 | -1.11 | -654.65万 | -6.44 |
17 | 600521 | 华海药业 | 21.72 | -1.05 | -2165.41万 | -2.22 |
18 | 300009 | 安科生物 | 9.4 | -0.95 | -1550.39万 | -3.67 |
19 | 688626 | 翔宇医疗 | 46.2 | -0.94 | -1696.10万 | -9.85 |
20 | 301301 | 川宁生物 | 12.47 | -0.87 | -3314.78万 | -10.88 |
板块涨幅居前的股票包括:健康元(3.57%)、塞力医疗(1.65%)、荣科科技(1.2%)、国新健康(1.01%)、万东医疗(0.96%)、美迪西(0.88%)、长春高新(0.63%)、泓博医药(0.59%)、翰宇药业(0.59%)、柳药集团(0.46%)、诺思格(0.32%)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.